Improving care coordination for patients with coronary heart disease - a new healthcare programme (Cardiolotse)

Conditions

I20-I25 I47 I48 I49 I50

Saskia Kropp, Wiebke Schüttig, Marie Barzen Coors, Katrin C. Reber, Harald Darius et al. (11 authors)

BMC Health Services Research2026-09-09

Cost-effectiveness and cost-utility analysis of a nurse-led, transitional care model to improve care coordination for patients with cardiovascular diseases: results from the “Cardiolotse” study

Marie Coors, Wiebke Schüttig, Katrin Christiane Reber, Harald Darius, Alfred Holzgreve et al. (11 authors)

The European Journal of Health Economics2024-11-063 citations

10.1007/s10198-024-01734-7

Reducing rehospitalization in cardiac patients: a randomized, controlled trial of a cardiac care management program ("Cardiolotse") in Germany.

Schüttig W, Darius H, Reber KC, Coors M, Flothow A, Holzgreve A, Karmann S, Stürtz A, Zöller R, Kropp S, Riesner P, Sundmacher L.

2024-10-211 citations

10.1186/s12916-024-03691-7

Improving care coordination for patients with cardiac disease: Study protocol of the randomised controlled new healthcare programme (Cardiolotse)

Isabel Geiger, Katrin Christiane Reber, Harald Darius, Alfred Holzgreve, Sebastian Karmann et al. (9 authors)

Contemporary Clinical Trials2021-01-278 citations

10.1016/j.cct.2021.106297

Interventions

Group 1: Patients with CHD (coronary heart disease) receiving care coordination and transition assistance services ("Cardiolotse"). Group 2: Patients with CHD receiving care as usual i.e. no care coor

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: insured through a participating health insurance provider, age = 18 years, CHD (ICD-10-GM I20-I25, I47-I50), written informed consent

Exclusion criteria

Exclusion criteria: care level =4, nursing home residents, cognitive or severe psychiatric disorders (ICD-10-GM F20-29; F33.3)

Design outcomes

Primary

Measure	Time frame
Hospital readmission rate (after 12 months)	—

Secondary

Measure	Time frame
mortality, avg. length of inpatient stays, health-related quality of life (EQ5D)	—

Countries

Germany

Contacts

Public ContactSebastian Karmann

Vivantes Netzwerk für Gesundheit GmbH

Sebastian.Karmann@vivantes.de+49 30 130 111005

Outcome results

None listed